No Mutations of Lysophosphatidic Acid Receptor Genes in Lung Adenocarcinomas Induced by N-Nitrosobis(2-Hydroxypropyl)amine in Rats

Journal of Toxicologic Pathology - Japan
doi 10.1293/tox.23.63
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Toxicologic Pathology

Related search

ARID1A Gene Driver Mutations in Lung Adenocarcinomas

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Functional Significance of U2AF1 S34F Mutations in Lung Adenocarcinomas

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Activation of Serum Response Element-Regulated Genes by Lysophosphatidic Acid

Nucleic Acids Research
Genetics
1994English

Lysophosphatidic Acid Type 2 Receptor Agonists in Targeted Drug Development Offer Broad Therapeutic Potential

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

Lysophosphatidic Acid Receptor 1 (LPAR1; EDG2; LPA1)

Science-Business eXchange
2011English

Neurobiology of the Edg2 Lysophosphatidic Acid Receptor.

The Japanese Journal of Pharmacology
2001English

Destabilization of Lysophosphatidic Acid Receptor 1 Reduces Cytokine Release and Protects Against Lung Injury

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

-Arrestin 2 Is Required for Lysophosphatidic Acid-Induced NF- B Activation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Complex Epidermal Growth Factor Receptor Mutations and Their Responses to Tyrosine Kinase Inhibitors in Previously Untreated Advanced Lung Adenocarcinomas

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy